Printer Friendly

MERIDIAN BEGINS DISTRIBUTION OF RAPID TEST FOR STOMACH ULCERS.

Meridian Bioscience, Inc., (Nasdaq:VIVO), Cincinnati, has begun international distribution of its patent protected ImmunoCard Stat! HpSA rapid test for Helicobacter pylori bacteria, the primary cause of stomach ulcers. The ImmunoCard STAT! HpSA test is highly accurate, simple to perform, and yields results in just five minutes. The speed and simplicity of the test makes it ideal for use in quickly diagnosing, treating and monitoring successful eradication of the H.pylori infection.

Helicobacter pylori infection is a global problem affecting approximately three billion people. Although most commonly implicated as the primary cause of stomach ulcers, H.pylori is now recognized as a direct cause of adenocarcinoma of the stomach.

Antonio Interno, senior vice president, managing director Meridian Bioscience Europe, stated, "We are excited about the potential of this new rapid test. The early acceptance of the ImmunoCard STAT HpSA test from our customers and distribution partners has been very positive. This new test is the perfect complement to our Premier Platinum HpSA test and enables us to provide important new diagnostic capabilities to any size laboratory with these patented technologies."

Meridian is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these products provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral, urinary and respiratory infections. All Meridian products are used outside of the human body and require little or no special equipment. The company's products are designed to enhance patient well-being while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal and upper respiratory infections, serology, parasitology and fungal disease diagnosis. In addition, Meridian is a supplier of rare reagents and specialty biologicals. The company markets its products to hospitals, reference laboratories, research centers, veterinary testing centers and physician offices in more than 60 countries around the world. The company's shares are traded through Nasdaq's National Market, symbol VIVO.

For more information, visit www.meridianbioscience.com or call 513/271-3700.
COPYRIGHT 2002 Worldwide Videotex
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Comment:MERIDIAN BEGINS DISTRIBUTION OF RAPID TEST FOR STOMACH ULCERS.
Publication:Worldwide Biotech
Geographic Code:1USA
Date:Sep 1, 2002
Words:354
Previous Article:GENEFORMATICS/DE NOVO FORM DRUG DISCOVERY COLLABORATION.
Next Article:FDA GRANTS "APPROVABLE" STATUS FOR TEVA'S ANDA FOR GABAPENTIN.


Related Articles
What is dyspepsia?
Stomach ulcers.
Ulcer-causing bacteria found in water.
Stomach and duodenal ulcers.
Is Your Stomach Bugging You?
Bacteria in Drinking Water Linked Directly to Stomach Ulcers.
Cancer and H. Pylori. (Quick Studies).
Molecule could be key to stomach ailment. (Ulcer Clue?).

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters